Alzheimer; News from the web:
A team led by Dr Laura Ferraiuolo of The University of Sheffield have found that AI could be used to assess and monitor potential patients. Specifically, machines could be programmed to recognise Alzheimer’s by looking at an image of a patient’s brain, as well as assessing their movements and speech to determine if they are likely to be suffering from the condition before symptoms progress.
http://forgetoday.com/
Read all about it HERE
Alzheimer; News from the web:
Researchers compared the navigation performance of 202 volunteers without genetic Alzheimer’s risk and 65 volunteers with increased genetic risk. The latter had a specific expression of the gene for apolipoprotein E, the APOE-ε4 allele.
Source:
Ruhr-Universitaet-Bochum
Journal reference:
Bierbrauer, A., et al. (2020) Unmasking selective path integration deficits in Alzheimer’s disease risk carriers. Science Advances. doi.org/10.1126/sciadv.aba1394.
Read all about it HERE
Alzheimer; News from the web:
An interesting development is that apparently an experimental drug, aimed to help people with Alzheimer’s, could play a role in helping children with certain types of Autims. Read the full story in our link for today.
Read all about it HERE
Alzheimer; News from the web:
Clinical trials of Alzheimer’s medicines have failed frequently but now researchers believe that this may have been caused by the drugs given too late. So if they could just develop a test that would detect Alzheimer’s earlier, it would make the drugs that have failed for use later in the process, so much more productive.
Read all about it HERE
Alzheimer; News from the web:
The first drug shown to potentially delay the progression of Alzheimer’s disease could be approved next year.
The Food and Drug Administration (FDA) in the United States said that aducanumab had been accepted for a priority review process.
Read all about it HERE
Alzheimer; News from the web:
Flu and pneumonia vaccines were associated with a lower risk of developing Alzheimer’s disease among thousands of adults over age 60, according to two new studies presented Monday at the Alzheimer’s Association International Conference.
The studies haven’t been published.
Read all about it HERE